Rising High: Exclusive talk with Michigan cannabis operator Gage Growth » 12:4007/2207/22/21
GAEGF, ACB, CVSI, CTST, CGC, CRON, CANN, GDNSF, GTBIF, IGC, TLRY, TCNNF, ZYNE
In this edition of…
Glass Lewis recommends Tilray holders vote for all company's proposals » 16:3307/2107/21/21
Tilray announced that…
Tilray announced that Glass Lewis, an independent provider of proxy research and vote recommendations to the investment community, has joined the other major independent proxy research firm, ISS, in recommending that Tilray shareholders vote "FOR" the company's proposals at Tilray's Special Meeting of Stockholders to be held on July 29, 2021. "We are pleased that the two major independent proxy advisory firms both agree that shareholders should support all of the proposals on the agenda for the upcoming Special Meeting of shareholders," said Irwin D. Simon, Tilray's Chairman and Chief Executive Officer. "Proposal 1, in particular, is a critical part of our strategy to capture market share and drive profitable growth. Glass Lewis' endorsement affirms our conviction that Proposal 1 is in the best interest of our shareholders."
Village Farms price target raised to C$22.50 from C$22 at Stifel » 11:0807/2107/21/21
Stifel analyst Andrew…
Stifel analyst Andrew Partheniou raised the firm's price target on Village Farms to C$22.50 from C$22 and keeps a Buy rating on the shares.
Sundial Growers upgraded to Sector Perform from Underperform at ATB Capital » 16:5807/2007/20/21
ATB Capital analyst David…
ATB Capital analyst David Kideckel upgraded Sundial Growers to Sector Perform from Underperform with a price target of 80c, up from 50c. The analyst changed his rating after Sundial announced the closing of the acquisition of Inner Spirit Holdings, adding that he is revamping his model to factor an improved fundamental outlook. The analyst said the company is a very different business from a year ago, and the rise of a new Sundial led by Zach George and team could present an "attractive" opportunity for investors.
High Tide subsidiary High Tide USA acquires online retailer DankStop for $3.85M » 12:4807/2007/20/21
High Tide announced that…
High Tide announced that it has entered into a definitive agreement pursuant to which High Tide USA Inc., a wholly-owned U.S. subsidiary of the company will acquire 100% of the issued and outstanding shares of DS Distribution, operating as DankStop.com, for $3.85M. "This acquisition is yet another example of how High Tide's U.S. e-commerce infrastructure and network keep getting stronger. Rolling multiple established e-commerce platforms into our network is positioning us nicely to create numerous synergies and efficiencies across our ecosystem. Along with this transaction, our last two acquisitions have increased High Tide's social media reach by leaps and bounds, giving us access to an invaluable potential customer base," said Raj Grover, President and CEO of High Tide. The DankStop acquisition will be immediately accretive, the company said. the Transaction has been unanimously approved by the board of directors of High Tide and DankStop.
High Tide to acquire DankStop for $3.85M, sees accretion » 06:4907/2007/20/21
High Tide announced that…
High Tide announced that it has entered into a definitive agreement pursuant to which High Tide USA, a wholly-owned U.S. subsidiary of the company will acquire 100% of the issued and outstanding shares of DS Distribution, or DankStop, operating as DankStop.com for $3.85M. The DankStop acquisition will be immediately accretive and its growing base of over 200,000 email subscribers provides High Tide with another sales channel on which to sell its products. Although currently operating in the hemp-derived CBD and consumption accessories space, High Tide intends to expand its cannabis retail network into the United States in the event of federal legalization, through cannabis subscription boxes, mature e-commerce sites and bricks and mortar locations. Upon closing of the transaction DankStop co-founder Feliks Khaykin and director Gabe Aronovich will be joining the High Tide team with Feliks taking on the role of Director of U.S. Operations and Gabe coming on as Director of U.S. Business Development. The transaction, which is an arm's length transaction, is subject to, among other things, receipt of required TSX Venture Exchange approval, and other customary conditions of closing, is expected to close in the coming weeks. Pursuant to the terms of the Transaction, High Tide USA, a Nevada corporation and a wholly-owned subsidiary of High Tide, will purchase 100% of the issued and outstanding shares of DankStop. The consideration for the 100% of DankStop acquired will be $3.85M in common shares of High Tide on the basis of a deemed price per High Tide Share equal to the volume weighted average price per High Tide Share on the TSXV for the 10 consecutive trading days preceding closing of the transaction. Upon closing, DankStop will have approximately $100,000 of cash and non-cash working capital and inventory of approximately $220,000. Following the completion of the transaction, DankStop will continue its corporate existence under the state of Delaware as a 100% owned subsidiary of High Tide USA. The transaction has been unanimously approved by the board of directors of High Tide and DankStop. The High Tide Shares issued pursuant to the consideration are subject to a statutory hold period of four months and one day.
Aleafia Health launches cannabis brand Nith & Grand » 07:4007/1907/19/21
Aleafia Health announce…
Aleafia Health announce the launch of its premium cannabis brand Nith & Grand. The initial launch features TF Pink Kush Live Resin vape cartridges, which comprises a hydrocarbon extraction process utilizing fresh-frozen cannabis flower that preserves the strain's natural flavour, aroma and terpene profile. The new product features the sought after and not yet widely available TF Pink Kush strain. "Nith & Grand completes our highly differentiated brand portfolio, allowing us to reach the growing market for premium, craft cannabis products. With a collection of highly sought after cultivars and six years operating our craft cultivation facility in Paris, Ont., we are perfectly situated to delight cannabis connoisseurs," said Aleafia Health CEO Geoffrey Benic.
|Over a week ago|
Rising High: Exclusive talk with cannabinoid-based medicine company Cannabics » 11:2607/1507/15/21
CNBX, ACB, CVSI, CTST, CGC, CRON, CANN, GDNSF, GTBIF, IGC, TLRY, TCNNF, ZYNE
In this edition of…
Organigram price target lowered to C$3.75 from C$4 at Stifel » 11:0707/1507/15/21
Stifel analyst Andrew…
Stifel analyst Andrew Partheniou lowered the firm's price target on Organigram to C$3.75 from C$4 and keeps a Hold rating on the shares.
Organigram price target raised to C$4 from C$3.75 at CIBC » 12:0807/1407/14/21
CIBC analyst John Zamparo…
CIBC analyst John Zamparo raised the firm's price target on Organigram to C$4 from C$3.75 and keeps a Neutral rating on the shares.